Stop falling for misleading headlines. Understand the difference between correlation and causation, and learn how researchers prove real scientific facts.
Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after 2 or more HER2-directed chemotherapies (KM-10A/KCSG BR18-13). This is ...
Zanidatamab (zani) in previously treated HER2+ biliary tract cancer (BTC): Impact on patient-reported pain outcomes in the phase 2b HERIZON-BTC-01 study. Analysis of patients (pts) with unresectable ...
Clinical data review and analysis is a cornerstone of modern pharmaceutical research and development. With the growing complexity of clinical trials and regulatory requirements, accurate and efficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results